Cancer Research UK logo.
SearchDonate
  • Search

A trial of lenvatinib, pembrolizumab and chemotherapy for non small cell lung cancer (LEAP-006)

Overview

Cancer types:

Lung cancer, Non small cell lung cancer (NSCLC), Secondary cancers

Status:

Closed

Phase:

Phase 3

Details

This trial is for people with advanced non small cell lung cancer (NSCLC). Advanced NSCLC can mean one of the following:

  • the cancer is in both lungs

  • the cancer has spread outside of the lungs into the surrounding area, or elsewhere in the body

  • there is a collection of fluid around the lung (pleural effusion) and this fluid contains cancer cells

It is for people who are going to have treatment for advanced NSCLC for the first time.

Recruitment start: 28 June 2019

Recruitment end: 29 January 2021

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Dr Samreen Ahmed

Supported by

Merck Sharp & Dohme Ltd

Eisai

Last reviewed: 1 February 2021

CRUK internal database number: 16221

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Questions for your doctor

What to ask your doctor about clinical trials.

An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.